More EMA: New Update of the Q&A Documents on Centralised Procedures
More EDQM: Policy for CEP Applications published for Comments
More Ph. Eur. Monographs for Cannabis Flower and CBD adopted
More COVID-19 Flexibilities also to be terminated in the GMP/GDP Environment
More EU-GMP: Is remote QP Batch Certification/Confirmation allowed?
More EMA publishes new and updated product-specific Bioequivalence Guidance
More GDP in the US: FDA Draft Guidance on Wholesaling under Section 503B of the FD&C Act
More Turkish Authority publishes new Guideline on GDP Inspections
More FDA now also assesses Countries and Regions as a Risk Factor
More How to determine the Protective Properties of Amber Glass Containers?
More Pharmeuropa: Revised Chapter 2.2.47. "Capillary electrophoresis" published for Comments
More 2nd Version of the USP Draft Guidance on mRNA-based Therapeutics
More Artificial Intelligence/Machine Learning in the Analysis of Biotherapeutics
More Potential Assays for Monoclonal Antibodies and Other Therapeutic Proteins
More Quality Culture in the Pharmaceutical Industry: Benefits and Challenges
More Packaging of Solid Dosage Forms: Warning Letter in the USA